{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:52:36Z","timestamp":1772308356896,"version":"3.50.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s11910-008-0038-6","type":"journal-article","created":{"date-parts":[[2008,5,28]],"date-time":"2008-05-28T19:56:50Z","timestamp":1212004610000},"page":"249-258","source":"Crossref","is-referenced-by-count":37,"title":["Neoplastic meningitis"],"prefix":"10.1007","volume":"8","author":[{"given":"Marc C.","family":"Chamberlain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,29]]},"reference":[{"key":"38_CR1","first-page":"733","volume":"61","author":"W.R. Shapiro","year":"1977","unstructured":"Shapiro WR, Posner JB, Ushio Y, et al.: Treatment of meningeal neoplasms. Cancer Treat Rep 1977, 61:733\u2013743.","journal-title":"Cancer Treat Rep"},{"key":"38_CR2","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/1097-0142(197911)44:5<1885::AID-CNCR2820440550>3.0.CO;2-F","volume":"44","author":"J.L. Nugent","year":"1979","unstructured":"Nugent JL, Bunn PA Jr, Matthews MJ, et al.: CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer 1979, 44:1885\u20131893.","journal-title":"Cancer"},{"key":"38_CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02341153","volume":"9","author":"J.G. Kaplan","year":"1990","unstructured":"Kaplan JG, DeSouza TG, Farkash A, et al.: Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 1990, 9:225\u2013229.","journal-title":"J Neurooncol"},{"key":"38_CR4","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1212\/WNL.44.8.1463","volume":"44","author":"T. Siegal","year":"1994","unstructured":"Siegal T, Lossos A, Pfeffer MR: Leptomeningeal metastases: analysis of 31 patients with sustained off-therapy response following combined-modality therapy. Neurology 1994, 44:1463\u20131469.","journal-title":"Neurology"},{"key":"38_CR5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/archneur.1997.00550130008003","volume":"54","author":"M.C. Chamberlain","year":"1997","unstructured":"Chamberlain MC: Carcinomatous meningitis. Arch Neurol 1997, 54:16\u201317.","journal-title":"Arch Neurol"},{"key":"38_CR6","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1212\/WNL.29.10.1369","volume":"29","author":"J.P. Glass","year":"1979","unstructured":"Glass JP, Melamed M, Chernik NL, et al.: Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 1979, 29:1369\u20131375.","journal-title":"Neurology"},{"key":"38_CR7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","volume":"49","author":"W.R. Wasserstrom","year":"1982","unstructured":"Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982, 49:759\u2013772.","journal-title":"Cancer"},{"key":"38_CR8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/archneur.1974.00490320026003","volume":"30","author":"J.R. Little","year":"1974","unstructured":"Little JR, Dale AJ, Okazaki H: Meningeal carcinomatosis. Clinical manifestations. Arch Neurol 1974, 30:138\u2013143.","journal-title":"Arch Neurol"},{"key":"38_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00005792-198201000-00005","volume":"61","author":"S.T. Rosen","year":"1982","unstructured":"Rosen ST, Aisner J, Makuch RW, et al.: Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experience. Medicine (Baltimore) 1982, 61:45\u201353.","journal-title":"Medicine (Baltimore)"},{"key":"38_CR10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-E","volume":"42","author":"M.H. Amer","year":"1978","unstructured":"Amer MH, AlSarraf M, Baker LH, et al.: Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978, 42:660\u2013668.","journal-title":"Cancer"},{"key":"38_CR11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/1097-0142(197807)42:1<283::AID-CNCR2820420142>3.0.CO;2-#","volume":"42","author":"H.Y. Yap","year":"1978","unstructured":"Yap HY, Yap BS, Tashima CK, et al.: Meningeal carcinomatosis in breast cancer. Cancer 1978, 42:283\u2013286.","journal-title":"Cancer"},{"key":"38_CR12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.53.2.382","volume":"53","author":"R.J. Oostenbrugge van","year":"1999","unstructured":"van Oostenbrugge RJ, Twijnstra A: Presenting features and value of diagnostic procedures in leptomeningeal metastases. Neurology 1999, 53:382\u2013385.","journal-title":"Neurology"},{"key":"38_CR13","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archneur.1996.00550070064013","volume":"53","author":"M. Balm","year":"1996","unstructured":"Balm M, Hammack J: Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol 1996, 53:626\u2013632.","journal-title":"Arch Neurol"},{"key":"38_CR14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0025-6196(12)60242-0","volume":"59","author":"S.C. Sorensen","year":"1984","unstructured":"Sorensen SC, Eagan RT, Scott M: Meningeal carcinomatosis in patients with primary breast or lung cancer. Mayo Clin Proc 1984, 59:91\u201394.","journal-title":"Mayo Clin Proc"},{"key":"38_CR15","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1002\/1097-0142(197606)37:6<2906::AID-CNCR2820370648>3.0.CO;2-D","volume":"37","author":"J.C. Gonzalez-Vitale","year":"1976","unstructured":"Gonzalez-Vitale JC, Garcia-Bunuel R: Meningeal carcinomatosis. Cancer 1976, 37:2906\u20132911.","journal-title":"Cancer"},{"key":"38_CR16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","volume":"25","author":"S.A. Grossman","year":"1999","unstructured":"Grossman SA, Krabak MJ: Leptomeningeal carcinomatosis. Cancer Treat Rev 1999, 25:103\u2013119.","journal-title":"Cancer Treat Rev"},{"key":"38_CR17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1005982826121","volume":"38","author":"M.C. Chamberlain","year":"1998","unstructured":"Chamberlain MC: Radioisotope CSF flow studies in leptomeningeal metastases. J Neurooncol 1998, 38:135\u2013140.","journal-title":"J Neurooncol"},{"key":"38_CR18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/pgmj.56.653.149","volume":"56","author":"R. Boyle","year":"1980","unstructured":"Boyle R, Thomas M, Adams JH: Diffuse involvement of the leptomeninges by tumour\u2014a clinical and pathological study of 63 cases. Postgrad Med J 1980, 56:149\u2013158.","journal-title":"Postgrad Med J"},{"key":"38_CR19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1005910203831","volume":"38","author":"G. Wolfgang","year":"1998","unstructured":"Wolfgang G, Marcus D, Ulrike S: Leptomeningeal carcinomatosis: clinical syndrome in different primaries. J Neurooncol 1998, 38:103\u2013110.","journal-title":"J Neurooncol"},{"key":"38_CR20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1005803918194","volume":"35","author":"M.C. Chamberlain","year":"1997","unstructured":"Chamberlain MC, Kormanik PR: Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy. J Neurooncol 1997, 35:55\u201364.","journal-title":"J Neurooncol"},{"key":"38_CR21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1005970406557","volume":"38","author":"H.W. Kolmel","year":"1998","unstructured":"Kolmel HW: Cytology of neoplastic meningosis. J Neurooncol 1998, 38:121\u2013125.","journal-title":"J Neurooncol"},{"key":"38_CR22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0002-9343(83)91207-X","volume":"75","author":"J.J. Murray","year":"1983","unstructured":"Murray JJ, Greco FA, Wolff SN, et al.: Neoplastic meningitis. Marked variations of cerebrospinal fluid composition in the absence of extradural block. Am J Med 1983, 75:289\u2013294.","journal-title":"Am J Med"},{"key":"38_CR23","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1212\/WNL.42.6.1239","volume":"42","author":"L.R. Rogers","year":"1992","unstructured":"Rogers LR, Duchesneau PM, Nunez C, et al.: Comparison of cisternal and lumbar CSF examination in leptomeningeal metastasis. Neurology 1992, 42:1239\u20131241.","journal-title":"Neurology"},{"key":"38_CR24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/neuonc\/3.1.42","volume":"3","author":"M.C. Chamberlain","year":"2001","unstructured":"Chamberlain MC, Kormanik PA, Glantz MJ: A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases. Neuro-oncology 2001, 3:42\u201345.","journal-title":"Neuro-oncology"},{"key":"38_CR25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z","volume":"82","author":"M.J. Glantz","year":"1998","unstructured":"Glantz MJ, Cole BF, Glantz LK, et al.: Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer 1998, 82:733\u2013739.","journal-title":"Cancer"},{"key":"38_CR26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1005956925637","volume":"38","author":"L.M. DeAngelis","year":"1998","unstructured":"DeAngelis LM: Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 1998, 38:245\u2013252.","journal-title":"J Neurooncol"},{"key":"38_CR27","first-page":"239","volume":"11","author":"W.R. Wasserstrom","year":"1981","unstructured":"Wasserstrom WR, Schwartz MK, Fleisher M, et al.: Cerebrospinal fluid biochemical markers in central nervous system tumors: a review. Ann Clin Lab Sci 1981, 11:239\u2013251.","journal-title":"Ann Clin Lab Sci"},{"key":"38_CR28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0009-8981(86)90009-4","volume":"161","author":"A.P. Zanten Van","year":"1986","unstructured":"Van Zanten AP, Twijnstra A, Hart AA, et al.: Cerebrospinal fluid lactate dehydrogenase activities in patients with central nervous system metastases. Clin Chim Acta 1986, 161:259\u2013268.","journal-title":"Clin Chim Acta"},{"key":"38_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0025-6196(12)61391-3","volume":"61","author":"G.G. Klee","year":"1986","unstructured":"Klee GG, Tallman RD, Goellner JR, et al.: Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis. Mayo Clin Proc 1986, 61:9\u201313.","journal-title":"Mayo Clin Proc"},{"key":"38_CR30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/jnnp.50.3.313","volume":"50","author":"A. Twijnstra","year":"1987","unstructured":"Twijnstra A, van Zanten AP, Hart AA, et al.: Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours. J Neurol Neurosurg Psychiatry 1987, 50:313\u2013320.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"38_CR31","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1212\/WNL.54.8.1670","volume":"54","author":"G. Stockhammer","year":"2000","unstructured":"Stockhammer G, Poewe W, Burgstaller S, et al.: Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis. Neurology 2000, 54:1670\u20131676.","journal-title":"Neurology"},{"key":"38_CR32","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1212\/WNL.50.4.1173","volume":"50","author":"M.C. Chamberlain","year":"1998","unstructured":"Chamberlain MC: Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers. Neurology 1998, 50:1173\u20131175.","journal-title":"Neurology"},{"key":"38_CR33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02228893","volume":"3","author":"J.A. Garson","year":"1985","unstructured":"Garson JA, Coakham HB, Kemshead JT, et al.: The role of monoclonal antibodies in brain tumour diagnosis and cerebrospinal fluid (CSF) cytology. J Neurooncol 1985, 3:165\u2013171.","journal-title":"J Neurooncol"},{"key":"38_CR34","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/bjc.1990.349","volume":"62","author":"A. Hovestadt","year":"1990","unstructured":"Hovestadt A, Henzen-Logmans SC, Vecht CJ: Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis. Br J Cancer 1990, 62:653\u2013654.","journal-title":"Br J Cancer"},{"key":"38_CR35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/jnnp.51.1.142","volume":"51","author":"W. Boogerd","year":"1988","unstructured":"Boogerd W, Vroom TM, van Heerde P, et al.: CSF cytology versus immunocytochemistry in meningeal carcinomatosis. J Neurol Neurosurg Psychiatry 1988, 51:142\u2013145.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"38_CR36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1005926624303","volume":"38","author":"R.J. Oostenbrugge Van","year":"1998","unstructured":"Van Oostenbrugge RJ, Hopman AH, Ramaekers FC, et al.: In situ hybridization: a possible diagnostic aid in leptomeningeal metastasis. J Neurooncol 1998, 38:127\u2013133.","journal-title":"J Neurooncol"},{"key":"38_CR37","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/ajcp\/88.5.570","volume":"88","author":"E.S. Cibas","year":"1987","unstructured":"Cibas ES, Malkin MG, Posner JB, et al.: Detection of DNA abnormalities by flow cytometry in cells from cerebrospinal fluid. Am J Clin Pathol 1987, 88:570\u2013577.","journal-title":"Am J Clin Pathol"},{"key":"38_CR38","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/BF00228576","volume":"86","author":"S. Biesterfeld","year":"1993","unstructured":"Biesterfeld S, Bernhard B, Bamborschke S, et al.: DNA single cell cytometry in lymphocytic pleocytosis of the cerebrospinal fluid. Acta Neuropathol (Berl) 1993, 86:428\u2013432.","journal-title":"Acta Neuropathol (Berl)"},{"key":"38_CR39","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1212\/WNL.51.3.906","volume":"51","author":"R.J. Oostenbrugge Van","year":"1998","unstructured":"Van Oostenbrugge RJ, Hopman AH, Arends JW, et al.: The value of interphase cytogenetics in cytology for the diagnosis of leptomeningeal metastases. Neurology 1998, 51:906\u2013908.","journal-title":"Neurology"},{"key":"38_CR40","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<543::AID-CNCR17>3.0.CO;2-4","volume":"77","author":"C.H. Rhodes","year":"1996","unstructured":"Rhodes CH, Glantz MJ, Glantz L, et al.: A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis. Cancer 1996, 77:543\u2013548.","journal-title":"Cancer"},{"key":"38_CR41","first-page":"590","volume":"34","author":"T.M. Cheng","year":"1994","unstructured":"Cheng TM, O\u2019Neill BP, Scheithauer BW, et al.: Chronic meningitis: the role of meningeal or cortical biopsy. Neurosurgery 1994, 34:590\u2013595.","journal-title":"Neurosurgery"},{"key":"38_CR42","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.40.3_Part_1.435","volume":"40","author":"M.C. Chamberlain","year":"1990","unstructured":"Chamberlain MC, Sandy AD, Press GA: Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain. Neurology 1990, 40:435\u2013438.","journal-title":"Neurology"},{"key":"38_CR43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1005914321578","volume":"38","author":"M. Schumacher","year":"1998","unstructured":"Schumacher M, Orszagh M: Imaging techniques in neoplastic meningiosis. J Neurooncol 1998, 38:111\u2013120.","journal-title":"J Neurooncol"},{"key":"38_CR44","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2214\/ajr.153.5.1039","volume":"153","author":"G. Sze","year":"1989","unstructured":"Sze G, Soletsky S, Bronen R, et al.: MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis. AJR Am J Roentgenol 1989, 153:1039\u20131049.","journal-title":"AJR Am J Roentgenol"},{"key":"38_CR45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000116780","volume":"32","author":"B. Schuknecht","year":"1992","unstructured":"Schuknecht B, Huber P, Buller B, et al.: Spinal leptomeningeal neoplastic disease. Evaluation by MR, myelography and CT myelography. Eur Neurol 1992, 32:11\u201316.","journal-title":"Eur Neurol"},{"key":"38_CR46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01059954","volume":"23","author":"M.C. Chamberlain","year":"1995","unstructured":"Chamberlain MC: Comparative spine imaging in leptomeningeal metastases. J Neurooncol 1995, 23:233\u2013238.","journal-title":"J Neurooncol"},{"key":"38_CR47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ana.410380111","volume":"38","author":"R.J. Freilich","year":"1995","unstructured":"Freilich RJ, Krol G, DeAngelis LM: Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 1995, 38:51\u201357.","journal-title":"Ann Neurol"},{"key":"38_CR48","first-page":"633","volume":"15","author":"R.L. Mittl Jr","year":"1994","unstructured":"Mittl RL Jr, Yousem DM: Frequency of unexplained meningeal enhancement in the brain after lumbar puncture. AJNR Am J Neuroradiol 1994, 15:633\u2013638.","journal-title":"AJNR Am J Neuroradiol"},{"key":"38_CR49","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1002\/1097-0142(19950615)75:12<2919::AID-CNCR2820751220>3.0.CO;2-9","volume":"75","author":"M.J. Glantz","year":"1995","unstructured":"Glantz MJ, Hall WA, Cole BF, et al.: Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status. Cancer 1995, 75:2919\u20132931.","journal-title":"Cancer"},{"key":"38_CR50","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0002-9343(82)90404-1","volume":"73","author":"S.A. Grossman","year":"1982","unstructured":"Grossman SA, Trump CL, Chen DC, et al.: Cerebrospinal flow abnormalities in patients with neoplastic meningitis. Am J Med 1982, 73:641\u2013647.","journal-title":"Am J Med"},{"key":"38_CR51","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1212\/WNL.46.6.1674","volume":"46","author":"M.C. Chamberlain","year":"1996","unstructured":"Chamberlain MC, Kormanik PA: Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastases. Neurology 1996, 46:1674\u20131677.","journal-title":"Neurology"},{"key":"38_CR52","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1212\/WNL.50.2.438","volume":"50","author":"W.P. Mason","year":"1998","unstructured":"Mason WP, Yeh SD, DeAngelis LM: 111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. Neurology 1998, 50:438\u2013444.","journal-title":"Neurology"},{"key":"38_CR53","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1212\/WNL.41.11.1765","volume":"41","author":"M.C. Chamberlain","year":"1991","unstructured":"Chamberlain MC, Corey-Bloom J: Leptomeningeal metastases: 111indium-DTPA CSF flow studies. Neurology 1991, 41:1765\u20131769.","journal-title":"Neurology"},{"key":"38_CR54","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1212\/WNL.52.1.214-b","volume":"52","author":"M.C. Chamberlain","year":"1999","unstructured":"Chamberlain MC, Kormanik P, Jaeckle KA, et al.: 111Indium-diethylenetriamine pentaacetic acid CSF flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. Neurology 1999, 52:216\u2013217.","journal-title":"Neurology"},{"key":"38_CR55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1005976003347","volume":"38","author":"J. Hildebrand","year":"1998","unstructured":"Hildebrand J: Prophylaxis and treatment of leptomeningeal carcinomatosis in solid tumors of adulthood. J Neurooncol 1998, 38:193\u2013198.","journal-title":"J Neurooncol"},{"key":"38_CR56","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/archneur.1997.00550230037013","volume":"54","author":"M.C. Chamberlain","year":"1997","unstructured":"Chamberlain MC, Kormanik PA: Prognostic significance of coexistent bulky metastatic central nervous system disease in patients with leptomeningeal metastases. Arch Neurol 1997, 54:1364\u20131368.","journal-title":"Arch Neurol"},{"key":"38_CR57","doi-asserted-by":"crossref","first-page":"A17","DOI":"10.1212\/WNL.60.6.17A","volume":"60","author":"M.C. Chamberlain","year":"2003","unstructured":"Chamberlain MC: Neoplastic meningitis-related encephalopathy: prognostic significance. Neurology 2003, 60:A17\u2013A18.","journal-title":"Neurology"},{"key":"38_CR58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM197507242930402","volume":"293","author":"W.R. Shapiro","year":"1975","unstructured":"Shapiro WR, Young DF, Mehta BM: Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 1975, 293:161\u2013166.","journal-title":"N Engl J Med"},{"key":"38_CR59","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1005991027029","volume":"38","author":"U. Berweiler","year":"1998","unstructured":"Berweiler U, Krone A, Tonn JC: Reservoir systems for intraventricular chemotherapy. J Neurooncol 1998, 38:141\u2013143.","journal-title":"J Neurooncol"},{"key":"38_CR60","first-page":"49","volume":"47","author":"D.I. Sandberg","year":"2000","unstructured":"Sandberg DI, Bilsky MH, Souweidane MM, et al.: Ommaya reservoirs for the treatment of leptomeningeal metastases. Neurosurgery 2000, 47:49\u201354.","journal-title":"Neurosurgery"},{"key":"38_CR61","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02327385","volume":"6","author":"W.T. Sause","year":"1988","unstructured":"Sause WT, Crowley J, Eyre HJ, et al.: Whole brain irradiation and intrathecal methotrexate in the treatment of solid tumor leptomeningeal metastases\u2014a Southwest Oncology Group study. J Neurooncol 1988, 6:107\u2013112.","journal-title":"J Neurooncol"},{"key":"38_CR62","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/archneur.55.4.506","volume":"55","author":"M.C. Chamberlain","year":"1998","unstructured":"Chamberlain MC, Kormanik P: Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy. Arch Neurol 1998, 55:506\u2013512.","journal-title":"Arch Neurol"},{"key":"38_CR63","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1005999228846","volume":"38","author":"T. Siegal","year":"1998","unstructured":"Siegal T: Leptomeningeal metastases: rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy? J Neurooncol 1998, 38:151\u2013157.","journal-title":"J Neurooncol"},{"key":"38_CR64","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1200\/JCO.1986.4.1.68","volume":"4","author":"L. Giannone","year":"1986","unstructured":"Giannone L, Greco FA, Hainsworth JD: Combination intraventricular chemotherapy for meningeal neoplasia. J Clin Oncol 1986, 4:68\u201373.","journal-title":"J Clin Oncol"},{"key":"38_CR65","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.1987.5.10.1655","volume":"5","author":"R.N. Hitchins","year":"1987","unstructured":"Hitchins RN, Bell DR, Woods RL, et al.: A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 1987, 5:1655\u20131662.","journal-title":"J Clin Oncol"},{"key":"38_CR66","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.1993.11.3.561","volume":"11","author":"S.A. Grossman","year":"1993","unstructured":"Grossman SA, Finkelstein DM, Ruckdeschel JC, et al.: Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. J Clin Oncol 1993, 11:561\u2013569.","journal-title":"J Clin Oncol"},{"key":"38_CR67","first-page":"3394","volume":"5","author":"M.J. Glantz","year":"1999","unstructured":"Glantz MJ, Jaeckle KA, Chamberlain MC, et al.: A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 1999, 5:3394\u20133402.","journal-title":"Clin Cancer Res"},{"key":"38_CR68","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","volume":"17","author":"M.J. Glantz","year":"1999","unstructured":"Glantz MJ, LaFollette S, Jaeckle KA, et al.: Randomized trial of a slow release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 1999, 17:3110\u20133116.","journal-title":"J Clin Oncol"},{"key":"38_CR69","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1015752331041","volume":"57","author":"K.A. Jaeckle","year":"2002","unstructured":"Jaeckle KA, Batchelor T, O\u2019Day SJ, et al.: An open trial of sustained-release cytarabine (Depocyt) for the intrathecal treatment of solid tumor neoplastic meningitis. J Neurooncol 2002, 57:231\u2013239.","journal-title":"J Neurooncol"},{"issue":"1Pt1","key":"38_CR70","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1227\/00006123-198801000-00016","volume":"22","author":"T. Siegal","year":"1988","unstructured":"Siegal T, Pfeffer MR, Steiner I: Antibiotic therapy for infected Ommaya reservoir systems. Neurosurgery 1988, 22(1 Pt 1):97\u2013100.","journal-title":"Neurosurgery"},{"key":"38_CR71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1040-8428(00)00115-3","volume":"37","author":"J.Z. Kerr","year":"2001","unstructured":"Kerr JZ, Berg S, Blaney SM: Intrathecal chemotherapy. Crit Rev Oncol Hematol 2001, 37:227\u2013236.","journal-title":"Crit Rev Oncol Hematol"},{"key":"38_CR72","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM197310112891503","volume":"289","author":"W.A. Bleyer","year":"1973","unstructured":"Bleyer WA, Drake JC, Chabner BA: Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia. N Engl J Med 1973, 289:770\u2013773.","journal-title":"N Engl J Med"},{"key":"38_CR73","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1764::AID-CNCR24>3.0.CO;2-1","volume":"82","author":"F. Bokstein","year":"1998","unstructured":"Bokstein F, Lossos A, Siegal T: Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy. Cancer 1998, 82:1756\u20131763.","journal-title":"Cancer"},{"key":"38_CR74","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.1998.16.4.1561","volume":"16","author":"M.J. Glantz","year":"1998","unstructured":"Glantz MJ, Cole BF, Recht L, et al.: High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol 1998, 16:1561\u20131567.","journal-title":"J Clin Oncol"},{"key":"38_CR75","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1212\/WNL.55.1.117","volume":"55","author":"W. Boogerd","year":"2000","unstructured":"Boogerd W, Dorresteijn LD, van der Sande JJ, et al.: Response of leptomeningeal metastases from breast cancer to hormonal therapy. Neurology 2000, 55:117\u2013119.","journal-title":"Neurology"},{"key":"38_CR76","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/A:1005944622003","volume":"38","author":"S.M. Blaney","year":"1998","unstructured":"Blaney SM, Poplack DG: New cytotoxic drugs for intrathecal administration. J Neurooncol 1998, 38:219\u2013223.","journal-title":"J Neurooncol"},{"key":"38_CR77","first-page":"1183","volume":"5","author":"J.H. Sampson","year":"1999","unstructured":"Sampson JH, Archer GE, Villavicencio AT, et al.: Treatment of neoplastic meningitis with intrathecal temozolomide. Clin Cancer Res 1999, 5:1183\u20131188.","journal-title":"Clin Cancer Res"},{"key":"38_CR78","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/A:1005948722912","volume":"38","author":"U. Herrlinger","year":"1998","unstructured":"Herrlinger U, Weller M, Schabet M: New aspects of immunotherapy of leptomeningeal metastasis. J Neurooncol 1998, 38:233\u2013239.","journal-title":"J Neurooncol"},{"key":"38_CR79","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/A:1005996606073","volume":"38","author":"H.B. Coakham","year":"1998","unstructured":"Coakham HB, Kemshead JT: Treatment of neoplastic meningitis by targeted radiation using 131I-radiolabelled monoclonal antibodies. J Neurooncol 1998, 38:225\u2013232.","journal-title":"J Neurooncol"},{"key":"38_CR80","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1005900807890","volume":"38","author":"F.D. Vrionis","year":"1998","unstructured":"Vrionis FD: Gene therapy of neoplastic meningiosis. J Neurooncol 1998, 38:241\u2013244.","journal-title":"J Neurooncol"},{"key":"38_CR81","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1200\/JCO.2006.09.7311","volume":"25","author":"J.I. Rubenstein","year":"2007","unstructured":"Rubenstein JI, Fridlyand J, Abrey L, et al.: Phase 1 study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma. J Clin Oncol 2007, 25:1350\u20131356.","journal-title":"J Clin Oncol"},{"key":"38_CR82","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/cncr.21828","volume":"31","author":"M.C. Chamberlain","year":"2006","unstructured":"Chamberlain MC, Wei-Tao DD, Groshen S: A phase 2 trial of intra-CSF etoposide in the treatment of neoplastic meningitis. Cancer 2006, 31:2021\u20132027.","journal-title":"Cancer"},{"key":"38_CR83","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1002\/cncr.10547","volume":"94","author":"M.C. Chamberlain","year":"2002","unstructured":"Chamberlain MC: Alpha-interferon in the treatment of neoplastic meningitis. Cancer 2002, 94:2675\u20132680.","journal-title":"Cancer"},{"key":"38_CR84","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1200\/JCO.2005.03.7689","volume":"24","author":"W.R. Shapiro","year":"2006","unstructured":"Shapiro WR, Schmid M, Glantz M, Miller JJ: A randomized phase III\/IV study to determine benefit and safety of cytarabine liposome injection for treatment of neoplastic meningitis [abstract]. J Clin Oncol 2006, 24(Suppl):1528.","journal-title":"J Clin Oncol"},{"key":"38_CR85","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.ejca.2004.08.012","volume":"40","author":"W. Boogerd","year":"2004","unstructured":"Boogerd W, van den Bent MJ, Koehler PJ, et al.: The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomized study. Eur J Cancer 2004, 40:2726\u20132733.","journal-title":"Eur J Cancer"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-008-0038-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-008-0038-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-008-0038-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:24:40Z","timestamp":1559435080000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-008-0038-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s11910-008-0038-6","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}